Skip to main navigation Skip to search Skip to main content

Vitamin e triggers poly(2-hydroxyethyl methacrylate) (PHEMA) embolic potential: A proposed application for endovascular surgery

  • Filippo Renò
  • , Vincenzina Traina
  • , Silvia Gatti
  • , Mario Cannas

Research output: Contribution to journalArticlepeer-review

Abstract

Poly(2-hydroxyethyl methacrylate) (PHEMA) is a biocompatible polymer used as embolizing agent for endovascular surgery. Blending of PHEMA with a hydrophobic and anti-oxidant agent, Vitamin E (Vit.E, 0.1-10%, w/v), modified PHEMA's haemocombatibility, evaluated measuring wettability, plasma protein adsorption along with whole blood coagulation time. The presence of Vit.E increases PHEMA's hydrophobicity and plasma protein adsorption (in particular albumin and Immunoglobulin G), while it also accelerates blood clot formation. These effects are developed due to a combination of issues such as surface hydrophobicity and plasma protein adsorption induced by the presence of Vit.E, suggesting that Vit.E blending could improve the use of PHEMA as embolizing agent.

Original languageEnglish
Pages (from-to)641-650
Number of pages10
JournalJournal of Biomaterials Science, Polymer Edition
Volume22
Issue number4-6
DOIs
Publication statusPublished - 1 Jan 2011

Keywords

  • Phema
  • albumin
  • blood clot
  • endovascular surgery
  • immunoglobulin g
  • vitamin e
  • wettability

Fingerprint

Dive into the research topics of 'Vitamin e triggers poly(2-hydroxyethyl methacrylate) (PHEMA) embolic potential: A proposed application for endovascular surgery'. Together they form a unique fingerprint.

Cite this